Genoptix Inc.

Carlsbad, Calif. • 760-268-6200 •

Exchange and Ticker: Nasdaq: GXDX

Filing Range: 5M shares @ $14.00 to $16.00

Offering Price: $17.00

Close on First Day: $25.35

Offering Size: $85.00M

Shares Outstanding: 15,619,290

Underwriters: Lehman Brothers

Co-managers: Banc of America Securities LLC/ Cowen

Company Counsel: Cooley Godward LLP

Manager Counsel: Latham & Watkins

Auditor: Ernst & Young LLP

Market Capitalization on 10/31/07: $385.80M

Close price at current month end: $24.70


Provides genetic testing and identification services. The company, formerly known as DNA Dynamics Inc., makes technology capable of simultaneously analyzing and isolating specific cells based on their differences at the atomic level. Genoptix has developed a technology, Optophoresis, that utilizes moving waves of light to characterize the biology of whole living cells. Competitors include Bio-Reference Laboratories Inc., Genzyme Corp., Laboratory Corporation of America Holdings and Quest Diagnostics Inc.


Alliance Technology Ventures, Chicago Growth Partners, Enterprise Partners Venture Capital, Kingsbury Associates, Lotus Development Corp., Mitsubishi Corp., Tullis-Dickerson & Co. Inc., U.S. Trust Private Equity

Source: Thomson Financial